GSK Leaving Pennsylvania Emergen-C Plant, Adding Voltaren To US OTC Line

 
• By Malcolm Spicer
  
GSK Carlisle
GSK is phasing out production at its Carlisle, PA, production facility by mid-2021 and will full exit the site by the end of that year.
HBW Podcast

Explore how consumer health is evolving. On the go.

David Ridley hosts in-depth conversations with industry leaders.

SpotifyApple PodcastsWebsite

More from Rx-to-OTC Switch

More from Health